News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

BOULDER, Colo., Feb. 5, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Leerink Swann Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, February 11, 2015

Time:

10:15 a.m. Eastern Time

Location:

The Waldorf Astoria, New York, NY

Webcast:


http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-EventDetails&EventId=5184603

 

LA02195LOGO

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-swann-global-healthcare-conference-300031621.html

SOURCE Array BioPharma Inc.